Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2445 (LINC02445) is a gene that encodes a long intergenic non-coding RNA (lincRNA), a type of RNA longer than 200 nucleotides that does not overlap with protein-coding genes. LincRNAs, including LINC02445, are often transcribed in a tissue-specific manner and can serve roles in gene expression regulation, chromatin modification, and interaction with other nucleic acids or proteins. However, as of now, there are no experimental studies or functional annotations that specify the biological roles, disease relevance, or therapeutic targeting of LINC02445. There are also no reported interactions with drugs or use as a biomarker. LINC02445 is a lincRNA gene per human gene annotation. GeneCards lists it, but without detailed functional or disease associations and without associations to targeted therapy or clinical diagnostics. General studies of lincRNAs demonstrate potential for diverse regulatory roles, including in disease, but LINC02445 itself is not yet functionally characterized in the scientific literature.
Not applicable—no interacting drugs or established functional targeting mechanisms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2445 (LINC02445).